Pr Julien Taïeb, a digestive oncologist at the Georges-Pompidou European Hospital (AP-HP), describes how the progress of personalized medicine is changing its practices in the treatment of digestive cancers.

Acute Myeloid Leukemia: identification of a new targeted therapy approach
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
